Skip to main content

Post-IPO Equity Biotechnology Companies

Explore 483 biotechnology startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
483
Total Funding
$2.1B
Avg Funding
$82.7M
Cities
19

Export 483 Post-IPO Equity Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Lund, Sweden
$1.4M
raised

Carbiotix is a pre-clinical stage therapeutics company focusing on low-cost gut health testing and microbiome modulators.

Feb 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Minnesota City, United States
$9.0M
raised

Panbela Therapeutics develops small molecule pharmaceuticals for the oncology and acute care markets.

Jan 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$50.3M
raised

Skye Bioscience is a pharmaceutical company developing new therapeutic outcomes for diseases.

Jan 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$15.0M
raised

Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.

Jan 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$172.5M
raised

Tourmaline Bio is a biotechnology company that develops medicines to treat inflammatory and immune diseases in patients.

Jan 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
La Jolla, United States
$150.0M
raised

Kura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers.

Jan 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$250K
raised

Better Therapeutics develops prescription software for treating cardiometabolic diseases.

Jan 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$100.0M
raised

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.

Jan 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Lexington, United States
$140.0M
raised

Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.

Jan 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Chesterland, United States
$10.7M
raised

Novaccess Global brings together technological assets, scientific, and executive team to accelerate taking these assets to market.

Jan 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Diego, United States

Longboard Pharmaceuticals delivers medicines with optimized pharmacology and pharmacokinetics to patients with rare neurological diseases.

Jan 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom
$5.1M
raised

GENinCode is a genetic testing business specializing in the risk assessment and prediction of cardiovascular disease.

Dec 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$14.4M
raised

Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.

Dec 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Watertown, United States
$45.0M
raised

Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.

Dec 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$1.3M
raised

IamFire is an investment firm that invests in a range of sectors like natural resource, life science and biotechnology.

Dec 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Stamford, United States
$275.0M
raised

SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.

Dec 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$143.8M
raised

Verve Therapeutics is a clinical-stage biotechnology company developing genetic medicines for cardiovascular disease.

Nov 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Tarrytown, United States
$7.0M
raised

PaxMedica is a biopharmaceutical company focused on developing innovative treatments for unmet needs in neurodevelopmental disorders.

Nov 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Redwood City, United States
$200.0M
raised

Arcellx develops engineered cell-based immunotherapies for the treatment of cancer and other serious diseases.

Nov 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Seattle, United States
$150.0M
raised

Alpine Immune Sciences is an immunotherapy company focused on developing treatments for autoimmune and inflammatory diseases.

Nov 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
New York, United States
$5.0M
raised

Avenue Therapeutics is a specialty pharmaceutical company that acquires/in-licenses, develops and commercializes products.

Oct 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Carlsbad, United States
$1.4M
raised

Aurora is an early-stage start-up company focused on bringing advanced solutions to the spinal implant market.

Oct 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$100.0M
raised

Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.

Oct 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$450.0M
raised

Cerevel Therapeutics is a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric disorders.

Oct 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$21.0M
raised

Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases.

Sep 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 376 to 400 of 483 companies

Ready to Connect with Post-IPO Equity Biotechnology Startups?

Get verified founder emails, funding details, and company data for 483 post-ipo equity biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

483 Biotechnology Post-IPO Equity Startups (November 2026) — Page 16 | VCBacked